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The role of CD8 T cells in the pathogenesis of asthma
remains controversial, as both pro- and anti-inflam-
matory functions have been suggested. This study was
designed to examine the endogenous CD8 T cell re-
sponse in a biphasic ovalbumin (OVA)–induced
model of allergic airway disease (AAD) and its subse-
quent resolution with the development of local inha-
lational tolerance (LIT). We observed increases in
OVA-specific CD8 T cell numbers in the local lung
compartments (bronchoalveolar lavage, lung tissue,
hilar lymph node) at AAD and LIT; systemic compart-
ments (spleen, inguinal lymph node) displayed no
such increases in CD8 T cell numbers. OVA-specific
CD8 T cells appeared to exhibit plasticity both phe-
notypically and functionally. They possessed pro-in-
flammatory characteristics at AAD, with high pheno-
typic expression of CD11a and increased functional
expression of granzyme B and interferon-. In con-
trast, at LIT they showed increased phenotypic ex-
pression of the inhibitory marker NKG2A and func-
tionally did not produce granzyme B or interferon-.
In addition, in a discontinuous model the OVA-spe-
cific CD8 T cells could be recalled on re-exposure to
OVA, demonstrating memory. Finally, confocal mi-
croscopy results showed that OVA-specific CD8 T
cells at AAD are associated with B cell aggregates in
lung tissue. These B cell aggregates resembled tertiary
ectopic lymphoid tissue and may thus provide a local
environment for the salient cellular interactions that
contribute to the development of LIT. (Am J Pathol
2012, 180:1991–2000; DOI: 10.1016/j.ajpath.2012.01.043)Research over the last three decades has provided evi-
dence that T helper 2 (Th2) CD4 lymphocytes are a
major contributor to the development of allergic airway
disease (AAD) in animals and asthma in humans.1–3
These Th2 cells produce cytokines that promote many of
the features associated with AAD, including B cell class
switching and production of IgE (IL-4), lung eosinophilia
(IL-5), and increased mucus levels (IL-13). Furthermore,
in murine models of AAD, CD4Foxp3 T regulatory cells
(Tregs) have been shown to play a role in resolution of the
disease and the onset of local inhalational tolerance
(LIT).4,5 Analogous to CD4 Th1 and Th2 cells, CD8 T
cells are capable of forming cytokine-specific subsets
termed Tc1 and Tc2 cells, respectively.6 In addition,
CD8 T cells can develop into cytotoxic T-lymphocytes
(CTLs), which express granzyme, produce interferon
(IFN)–, and are capable of antigen-specific killing
through T-cell receptor recognition of the cognate anti-
gen presented on MHC I.7 Although it is apparent that
Th2 cells play a critical role in the development of AAD
and Tregs in the resolution phase at LIT, the role of CD8
T cells has not been fully elucidated.
Both pro- and anti-inflammatory roles have been dem-
onstrated for CD8 T cells in the development of AAD
and asthma.8–14 Although CD8 T cells have not been
directly implicated with eosinophilia, it has been demon-
strated that they contribute to airway hyperresponsive-
ness (AHR) in animals during AAD.11,13 Certain models
have also been shown to elicit Tc2 CD8 T cells, which
produce the Th2 cytokines associated with asthma.12,14
Conversely, in other models, CD8 T cells have been
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nophilic airway inflammation.14,16 Previously, in a bipha-
sic ovalbumin (OVA)–induced murine model of AAD, in
which resolution occurs with long-term continuous anti-
gen challenge, our laboratory has demonstrated in-
creased numbers of CD8 cells in lung tissue and in the
bronchoalveolar lavage (BAL) at AAD and LIT compared
with that in sensitized animals, and increases in these
cells in the draining lymph node at LIT.4 Other investiga-
tors have demonstrated that the magnitude of the anti-
gen-specific CD8 T cell responses generated during
AAD is dependent on the dose of antigen used during
sensitization and inversely correlated with the severity of
disease.17 Together, these findings suggest a possible
role for antigen-specific CD8 cells in the development of
AAD and LIT.
Using the biphasic OVA-induced model of AAD, we
examined the distribution of endogenous OVA-specific
CD8 T cells (OVA-TET) in the local lung compartments
and systemic tissues via flow cytometry and confocal
microscopy. The purpose of this study was to determine,
using phenotypic and functional assessments, whether
endogenous CD8 T cells were comparable or exhibit
plasticity at each stage (AAD and LIT) of the biphasic
OVA-induced model.
Materials and Methods
Animals and OVA Exposure Protocol
Specific pathogen free (SPF) female C57BL/6J mice
(stock number 000664) were obtained from The Jack-
son Laboratory (Bar Harbor, ME). The results for test-
ing of various viruses, bacteria, and mycoplasma or-
ganisms for shipment were provided by the Jackson
Laboratory, confirming SPF status. The SPF status dur-
ing housing at the University of Connecticut Health
Center (UCHC) is verified with quarterly serological
testing. The only pathogen that tested positive was the
ubiquitous mouse norovirus (MNV). Mice were not
tested for antibodies to cilia-associated respiratory
(CAR) bacillus. Regarding possible bacillus contami-
nation, we have not observed any abnormal lung pa-
thology in control naive or OVA-sensitized mice. The
mice were housed in IVC cages stored in a Thoren unit
for ventilation in the animal facility at the University of
Connecticut Health Center and were treated in accor-
dance with all Institutional and Office of Laboratory
Animal Welfare guidelines. As previously de-
scribed4,18,19 and as shown in Figure 1, mice were
immunized weekly with intraperitoneal injections of 25
g OVA in 2 mg of alum for 3 consecutive weeks
(sensitized). Starting 1 week after the last injection,
mice were exposed to 1% aerosolized OVA in physio-
logical saline, 1 hour per day (estimated inhaled daily
dose of 30–40 g/mouse), following one of four proto-
cols classified as either conventional or discontinuous
models (Figure 1). Conventional models (Figure 1A)
were as follows: i) Allergic Airway Disease (AAD), in
which sensitized mice were exposed to OVA aerosol 1hour per day for 7 days (7-day continuous); and ii)
resolution or Local Inhalational Tolerance (LIT), in
which sensitized mice were exposed to OVA aerosol 1
hour per day for 7 days, followed by 1 hour per day, 5
days per week for 4 weeks, then 1 hour per day for 7
days (6-week continuous). Discontinuous models (Fig-
ure 1B) included the following: iii) 6-week discontinu-
ous, whereby mice were sensitized and received OVA
aerosol following the AAD protocol. This was followed
by no aerosol exposure for 4 weeks, and then an ad-
ditional 7 days of OVA aerosol for 1 hour per day. In the
last model, iv) 11-week discontinuous, mice were sen-
sitized and exposed to OVA following the LIT protocol,
then no aerosol exposure for 4 weeks and then an
additional 7 days OVA aerosol for 1 hour per day. AAD
and LIT rested groups were used as controls for the
discontinuous models, which, following AAD or LIT,
received 4 to 5 weeks of no aerosol before sacrifice.
Bronchoalveolar Lavage and Tissue Analysis
At sacrifice, bronchoalveolar lavage (BAL) fluid, hilar
lymph node (HLN), lung tissue, inguinal lymph node
(ILN), and the spleen from each animal was harvested
and processed for the isolation and enumeration of leu-
kocytes. It should be noted that our use of the term “HLN”
more specifically refers to the tracheobronchial lymph
node, whereas “ILN” refers to the subiliac lymph node.20
We use the more generic HLN and ILN to represent the
region, as they are commonly used in many publications.
For collection of BAL, lungs were lavaged in situ with five
1.0-mL aliquots of sterile saline. Lymph nodes and
spleens were harvested and mechanically disrupted into
a single-cell suspension. Lung tissues were minced and
treated with collagenase solution (150 U/mL, Gibco,
Grand Island, NY) for 1 hour at 37°C. The minced tissue
was mechanically disrupted through a 40-m nylon filter
(BD Falcon, Bedford, MA). For the lung tissue and
spleen, red blood cells were lysed with Tris ammonium
chloride. For all tissue samples, total nucleated cell
counts were obtained using a hemocytometer with ni-
Figure 1. Models of allergic airway disease. A: Conventional models of AAD
and LIT with continuous aerosol of OVA post i.p. sensitization. B: Discon-
tinuous (6-week and 11-week) models of AAD with staggered aerosol of
OVA post i.p. sensitization. Dark gray and light gray areas represent weeks
in which animals received 7 days or 5 days of 1% OVA aerosol, respectively.
For each model group, the letter S indicates when animals were sacrificed.
Arrowheads indicate rested (no aerosol) control groups for the discontin-
uous models. These groups were euthanized after receiving 4 to 5 weeks of
rest subsequent to the initial aerosol protocol without receiving a second
challenge.grosin dye exclusion as a measure of viability.
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Flow Cytometry
The following monoclonal antibodies were used for cel-
lular surface staining: -CD8 (53–6.7), -CD3 (145-
2c11), -CD11a (2D7), -CD3 (145-2c11), -CD62L
(MEL-14), and -NKG2AB6 (16a11) and were purchased
from eBioscience (San Diego, CA) or BioLegend (San
Diego, CA). H-2Kb tetramers containing the OVA-derived
peptide SIINFEKL were generated in the laboratory as
described previously.21 After surface marker staining,
cells were lysed and fixed using Cytofix/perm buffer (BD
Pharmingen, San Jose, CA) as instructed by the manu-
facturer. Cells were then stained with -granzyme B
(GB11; eBioscience).
For intracellular cytokine staining, 1  106 cells from
the BAL, lung or HLN were plated in a 96-well plate and
treated with BD Golgi Plug (BD Pharmingen). Cells were
stimulated with SIINFEKL peptide or left unstimulated for
5 hours. Cells were then stained for surface cell markers,
treated with Cytofix/perm buffer (BD Pharmingen), fol-
lowed by intracellular cytokine staining with -IFN-
(XMG1.2), -IL-4(11B11), -IL-5 (TRFK5), or -IL-13
(ebio13A) (eBioscience). After staining, all samples were
run on a Becton Dickinson LSR II and analyzed with
FlowJo (Tree Star Inc., Ashland, OR) software. Standard
gating strategies based on isotype controls began by
gating on lymphocytes (side by forward scatter), which
was followed by gating on CD8 T cells (CD3 by CD8).
CD8 T cells were further gated by OVA-TET and CD11a
for identification of OVA-TET CD8 T cells. Since tissue
single cell suspensions are prepared differently, a spe-
cific gating strategy was used for each.
Enrichment of Antigen-Specific CD8 T Cells
Enrichment of OVA-TET CD8 T cells from sensitized and
naive mice were performed as previously described.22
Briefly, single cell suspensions from the spleen or pooled
lymph nodes (axillary, mandibular, cervical, HLN, ILN, colic,
jejunal, and caudal mesenteric) were prepared as de-
scribed above, stained with both phosphatidylethano-
lamine- and allophycocyanin (APC)-labeled tetramers and
-CD8 antibody. They were then stained with -phosphati-
dylethanolamine microbeads as per the instructions of the
manufacturer (Miltenyi Biotec, Auburn, CA). The samples
were then run on an AutoMACs (Miltenyi Biotec) magnetic
column cell separator. After enrichment, cells were stained
with -CD11a, -CD62L, -CD4, -CD19, -IAb, and
-CD11b for 30 minutes at 4°C. Cells were then washed
and fixed with 2% paraformaldehyde. The entire sample
was then analyzed with an LSRII cytometer (Becton Dickin-
son Biosciences, San Jose, CA).
Light and Confocal Microscopy
After sacrifice, nonmanipulated lungs from each animal
(n  4/group) not subjected to BAL were removed, fixed
with 10% buffered formalin, and processed in a standard
manner for light microscopy. Lung tissue were trans-
versely sliced/sectioned and stained with hematoxylinand eosin. All five lobes from each animal were examined
under light microscopy.
Whole-mount tissue preparations were used to visual-
ize the location of the endogenous CD8 T cells in the
lung tissue via confocal microscopy.23,24 Lung tissue
from sensitized, AAD, or LIT mice were transversely
sliced/sectioned into sections 300 to 500 m thick. Tis-
sues were washed and stained overnight at 4°C in round-
bottomed, 48-well plates with Cy5-labeled CD8a (53–6.7,
eBioscience), -B220 with Alexa Fluor 488 (Invitrogen,
Grand Island, NY), and APC-conjugated H-2Kb tetramer
containing the SIINFEKL (OVA366–374) peptide (1 g/mL)
diluted in 2% normal goat serum and 2% FBS/PBS solu-
tion. The tissues were extensively washed and fixed in 2%
paraformaldehyde for 2 hours at 4°C. The fixed tissues were
washed again with PBS and incubated overnight at 4°C.
The next day, the tissues were washed extensively and
were incubated overnight at 4°C with rabbit -APC anti-
body. The tissues were again washed extensively and in-
cubated overnight at 4°C with Alexa Fluor 546 goat anti-
rabbit IgG (Invitrogen). Stained tissues were washed
extensively and then mounted on slides using Immu-Mount
(Thermo Shandon, Pittsburgh, PA).
Images were collected using a Zeiss LSM-510-Meta con-
focal microscope mounted on an Axiovert 100M with auto-
mated xyz control equipped with an argon laser (emission
at 458, 488, and 514 nm), and two HeNe lasers (emission
wavelengths at 543 and 633 nm). Image analysis was per-
formed using Imaris Suite (Bitplane, South Windsor, CT).
Images were processed using the median filter algorithm.
Statistical Analysis
Normal distribution was determined via the Shapiro–Wilk
test. Statistical comparisons between the means of multiple
groups were made with analysis of variance followed by a
Student’s unpaired t-test. Comparisons between the mean
of two groups were made via unpaired t-test. All statistical
analysis was performed using JMP 5.1 statistical software
(SAS Institute, Cary, NC). In all comparisons, P  0.05 was
used to determine statistical significance.
Results
Endogenous OVA-TET CD8 T Cells Increase
in Local Lung Compartments (BAL, Lung, and
HLN) but Not in Systemic Tissues (Spleen and
ILN)
As shown in the representative dot plots (Figure 2A),
OVA-TET CD8 T cells were not identified in sensitized
mice in any of the local lung compartments or the sys-
temic tissues examined using our standard protocol for
isolating cells from tissue. Tetramer enrichment was used
to identify OVA-TET CD8 T cells and demonstrated
significantly increased numbers of OVA-TET CD8 T
cells in sensitized mice compared with naive animals
(see Supplemental Figure S1A at http://ajp.amjpathol.
org).22 In sensitized animals, increased numbers of these
cells were identified in the spleen as compared with the
ective tim
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frequency of these cells between the two compartments
(see Supplemental Figures S1, B and C at http://ajp.
amjpathol.org). At AAD, significant increases in the per-
centage of OVA-TET CD8 T cells were observed in the
local lung compartments compared with sensitized mice:
BAL 24% vs 1% (P 0.01); lung 17% vs 0.1% (P 0.01);
HLN 1% vs 0.1% (P  0.01) (Figure 2B). Unlike the HLN
and lung, the percentage of BAL OVA-TET CD8 T cells
was found to be increased at LIT (31%) as compared with
sensitized mice (P  0.01) and AAD (P  0.05; Figure
2B). Furthermore, at LIT, the percentages in the HLN
(0.5%) and lung (3.5%) were significantly decreased as
compared with AAD mice (HLN P  0.05; lung P  0.01)
but remained elevated over those tissues from sensitized
mice (P  0.05 each, Figure 2B). In the systemic tissues,
OVA-TET CD8 T cells were not detected at any of the
time points examined (Figure 2A).
In each of the local lung compartments, the total num-
ber of OVA-TET CD8 T cells significantly increased in
mice at AAD as compared with sensitized mice, and then
decreased in mice at LIT. The BAL at AAD had 13  103
OVA-TET CD8 T cells, as compared to 0.001  103
cells from sensitized mice (P  0.01) and 1.2  103 cells
from LIT mice (P  0.05); the lung at AAD had 74  103
CD8 T cells, as compared to 1.2  103 cells from
sensitized mice (P  0.01) and 8  103 cells from LIT
mice (P  0.01); the HLN had 6  103 OVA-TET CD8
T cells from AAD mice, as compared to 0.3  103 cells
from sensitized mice (P  0.01) and 3  103 cells from
LIT mice (P  0.05; Figure 2C).
Light Histopathology and Confocal Microscopy
Images of Lung Tissue from Sensitized, AAD,
and LIT Mice Demonstrate Prominent Lymphoid
Aggregates at AAD
Lymphoid aggregates of B cells (B220) were identi-
fied in lung tissue of mice at AAD (Figure 3, B and E)
but were absent in lung tissue from sensitized mice
(Figure 3, A and D). These aggregates were prominent
Figure 2. Identification of OVA-TET CD8 T cells in local lung compartments
at sensitization, AAD, and LIT, and OVA-TET CD8 T cells were isolated and co
compartments as described in the text. A: Representative dot plots from one m
identify all OVA-TET CD8 T cells in each tissue and time point. Mean values
and as total number (C) identified in the BAL, lung tissue, and HLN at each resp
tissues, and therefore the percentage and total numbers were not calculated. Din perivascular and peribronchial regions at AAD. Noaggregates could be found after 1 day of OVA aerosol,
and only small clusters were visualized after 3 days of
OVA aerosol (see Supplemental Figure S2 at http://ajp.
amjpathol.org). Larger aggregates were first observed
at 5 days of OVA challenge and peaked at 7 days
(AAD). After 14 days of OVA aerosol, these aggregates
had begun to diminish (see Supplemental Figure S2 at
http://ajp.amjpathol.org),23,24 and they remained at low
density at LIT (Figure 3, C and F).
OVA-TET CD8 T Cells Identified via Confocal
Microscopy in Lung Tissue of AAD Mice Are
Associated with Peribronchial and Perivascular
B Cell Aggregates
Few OVA-TET CD8 T cells could be visualized in lung
tissue of sensitized mice (Figure 4A), but these cells were
readily identified at AAD (Figure 4, B and D) with fewer
being seen at LIT (Figure 4C). The OVA-TET CD8 T
cells were found within the B-cell aggregates.
These B-cell aggregates were a common feature of
AAD, were widespread throughout the lung, and dem-
onstrated co-association with CD8 T cells (Figure
4D; see also Supplemental Figure S3 at http://ajp.
amjpathol.org).
Phenotypic Changes of Activation Markers
Occur in OVA-TET CD8 T Cells at AAD and
LIT
Expression of known T-cell activation markers CD11a
and CD62L was examined on CD8 T cells and OVA-
TET CD8 T cells in the local lung compartments of
sensitized, AAD and LIT mice (Figure 5). OVA-TET
CD8 T cells were not identifiable in the local lung
compartments of sensitized animals (data not shown).
In the entire CD8 T cell population, significant in-
creases in the percentage of CD11ahi cells were ob-
served in the BAL (53%) and lung (46%) at AAD as
compared with sensitized animals (BAL 23%, P  0.01;
temic tissues. Mice exposed to the conventional model protocol were sacrificed
m the various lung (BAL, lung tissue, HLN) and systemic tissue (ILN and spleen)
each group are shown for CD8 T cells gated on OVA-TET and CD11a; circles
-TET CD8 T cells for all mice in each group are shown as a percentage (B)
e point. OVA-TET CD8 T cells were below detectable levels in the systemic
esent the mean  SEM of six to eight mice per group, *P  0.05, **P  0.01.and sys
unted fro
ouse in
of OVAlung 25%, P  0.01 each) and LIT animals (BAL 27%,
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within the antigen-specific CD8 T cell subpopulation,
CD11ahi OVA-TET CD8 T cells at AAD were also
increased in BAL (90%) and lung (88%) compared withLIT (BAL 39%, P  0.01; lung 74%, P  0.01; Figure
5B). Thus, the percentage of CD11alo OVA-TET CD8
T cells increased at LIT in the BAL (61%) and lung
(26%) compared with AAD (BAL 10% and lung 12%).
Figure 3. Light histopathology and confocal mi-
croscopy images of lung tissue from sensitized,
AAD, and LIT mice demonstrating prominent
lymphoid aggregates at AAD. Mice at various
stages of the model (sensitized, AAD, and LIT)
were sacrificed and the lungs removed and pre-
pared for standard light and confocal microscopy
as described in the Materials and Methods.
Briefly, for light microscopy, formalin-fixed lung
tissue was processed in a standard manner and
stained with hematoxylin and eosin. For confo-
cal microscopy, freshly isolated lung tissue was
sliced/sectioned and stained with specific anti-
bodies overnight at 4°C before fixation with 2%
paraformaldehyde. Light microscopy images
(20) from the lungs of sensitized (A) and LIT
(C) mice appear normal, with no apparent infil-
tration of inflammatory cells. Prominent peri-
bronchial and perivascular inflammation was not
present in lungs of naive (not shown) or sensi-
tized animals (A), but was apparent with aggre-
gates of lymphoid-like cells in AAD mice (B).
Confocal microscopy images (20) confirmed
the absence of B-cell aggregates in sensitized
animals (D), but their presence at AAD (E). Cor-
responding with resolution of inflammation,
these lymphoid aggregates were considerably di-
minished in lung tissue from LIT mice (F). Aw 
airway. Images shown are from one representa-
tive mouse for each group and are consistent
with images from a total of four mice per group.
Figure 4. Confocal microscopy images identify
OVA-TET CD8 T cells in B-cell aggregates at
AAD. Mice at various stages of the model (sen-
sitized, AAD, and LIT) were sacrificed, and con-
focal microscopy was performed as described in
the Materials and Methods. In addition to the
general T and B cell stains, the APC-conjugated
H-2Kb tetramer containing the SIINFEKL
OVA366–374 peptide stain was used to identify
OVA-specific CD8 T cells. Representative lung
sections from sensitized (A), AAD (B), and LIT
(C) mice were assessed at low magnification
(10). B cell (B220) aggregates were visible at
AAD (B and D) and diminished considerably in
lung tissue from LIT mice (C). Digital zoom pho-
tograph (20) (D) taken from the white square
in B illustrates CD8 T cells and OVA-TET
CD8 T cells associated with the B-cell aggre-
gates. OVA-TET CD8 T cells are indicated
with white arrows. Green indicates B220
cells; blue indicates CD8 cells; and, with a dual
stain overlay, magenta represents OVA-TET
CD8 T cells. Images shown are from one rep-
resentative mouse for each group and are con-
sistent with images from a total of four mice per
group.
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on CD8 T cells or on OVA-TET CD8 T cells in the
HLN at the time points examined.
The percentages of CD62L CD8 T cells in sensi-
tized BAL (41%) and lung (70%) were significantly
increased compared with AAD (BAL 21%, P  0.01;
lung 34%, P  0.01) and LIT (BAL 13%, P  0.01; lung
59%, P  0.05) (Figure 5C). The percentage of
CD62L CD8 T cells rebounded toward sensitized
levels in lung at LIT compared with AAD (P  0.01).
There was a similar increase in CD62L CD8 T cells
in the HLN at LIT (75%) compared with AAD (58%, P 
0.01, Figure 5C). The percentage of CD62L OVA-
TET CD8 T cells observed in AAD BAL (2%) and
HLN (12%) were equivalent with those at LIT (BAL 1%;
HLN 12%). In the lung, there was a significant increase
of these cells at LIT (4%) compared with AAD (2%, P 
0.01, Figure 5D).Increased Percentages of NKG2A-Positive
OVA-TET CD8 T Cells in Lung
Compartments Are Observed at AAD and LIT
NKG2A has been shown to be a phenotypic marker of
regulatory CD8 T cells, which interact with Qa-1b.25
Few NKG2A CD8 T cells were found in BAL, lung,
and HLN of sensitized mice (1% each). The percent-
ages of NKG2A CD8 T cells significantly increased
at AAD in all compartments (BAL 22%, P  0.01; lung
8%, P  0.01; HLN 2%, P  0.01) and remained in-
creased at LIT (BAL 28%, P  0.01; lung 7% P  0.01;
HLN 1.5%, P  0.01). Compared with AAD, these cells
at LIT were significantly increased in BAL (P  0.05),
remained the same in lung, and were significantly de-
creased in HLN (P  0.05, Figure 6A). NKG2A OVA-
TET CD8 T cells were significantly increased at LIT
(BAL 52%; lung 51%) compared with AAD (BAL 39%,
Figure 5. Phenotypic changes on CD8 T cells
and OVA-TET CD8 T cells were identified in
the local lung compartments. Expression of
CD11a and CD62L were examined on CD8 T
cells (A, C) and OVA-TET CD8 T cells (B, D)
in BAL, lung tissue, and HLN of sensitized, AAD,
and LIT mice. OVA-TET CD8 T cells were not
identifiable in sensitized animals and therefore
are not included in B or D. Data represent the
mean  SEM of five to eight mice per group.
*P  0.05, **P  0.01.
Figure 6. Increased percentages of NKG2A-
positive OVA-TET CD8 T cells in lung com-
partments were observed at AAD and LIT. Ex-
pression of NKG2A was examined on CD8 T
cells (A) and OVA-TET CD8 T cells (B) in
BAL, lung tissue, and HLN of sensitized, AAD,
and LIT mice. OVA-TET CD8 T cells were not
identifiable in sensitized animals and therefore
are not included in B. Data represent the mean
SEM of five to eight mice per group. *P  0.05,
**P  0.01.
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was observed in these cells at LIT (12%) compared
with AAD (23%, P  0.01, Figure 6B).
Functional Changes, Granzyme B, and IFN-
Expression, Occur in CD8 T Cells at AAD and
LIT
Granzyme B
As demonstrated in representative dot plots (Figure 7),
OVA-TET CD8 T cells from the BAL, lung, or HLN were
analyzed for granzyme B expression. Granzyme B positive
OVA-TETCD8 T were observed in the BAL and in lung at
AAD but not at LIT or in the HLN. There was little granzyme
B detected in the CD8 T cells that were OVA-TET negative
(Figure 7A). At AAD, in the BAL and lung, 15% and 20% of
OVA-TET CD8 T cells were granzyme B, which was
significantly increased compared with LIT BAL 1% (P 
0.05) and lung 2% (P  0.05; Figure 7B).
IFN-
As demonstrated in representative dot plots, the BAL and
lung of AAD animals had an increased percentage of
IFN- CD8 T cells after OVA peptide stimulation, which
Figure 8. The percentage of CD8 T cells expressing IFN- production in res
Mice at various stages of the conventional model (AAD and LIT) were sacrific
expression was determined via flow cytometry. A: Representative dot plots f
and demonstrate increased double-positive cells in BAL and lung tissue at A
significantly elevated in the BAL and lung tissue at AAD as compared wit
nonstimulated control experiments (C). CD8 T cells positve for IFN- from BAL of sen
graphically. The data represent the mean  SEM of four to eight mice per group. *was not observed in the HLN (Figure 8A). The percentage
of IFN- CD8 cells in lung (2.5%) was significantly in-
creased in AAD lung (8%, P 0.01) but not in LIT lung (4%)
after peptide stimulation. A corresponding increase in the
percentage of IFN- CD8 cells was observed in the BAL
at AAD (7%) compared with LIT (4%, P 0.01) but was not
observed in the (HLN 1%) at any time point. The number
of IFN- CD8 cells isolated from the BAL of sensitized
mice decreased below the detectable level and are not
represented (Figure 8B). No changes were observed in the
percentage of IFN- CD8 T cells in unstimulated cells
from any of the lung compartments of sensitized, AAD, and
LIT animals (Figure 8C). In addition, CD8 T cells were
examined for Tc2 cytokines IL-4, IL-5, and IL-13 in the lung
compartments of sensitized, AAD, and LIT mice. Few
(1%) CD8 T cells produced any of the Tc2 cytokines
examined with or without peptide stimulation (data not
shown).
Increases in BAL Eosinophilia and OVA-TET
CD8 T Cells Are Observed in Discontinuous
Models
The number of BAL eosinophils and lymphocytes from
6-week discontinuously treated mice were significantly
increased compared with AAD rested animals (Figure
Figure 7. The percentage of OVA-TET CD8 T
cells expressing granzyme B was increased in BAL
and lung tissue at AAD. Mice at various stages of
the model (AAD and LIT) were sacrificed, and
OVA-TET CD8 T cells were isolated from the
BAL, lung tissue, and HLN. Intracellular granzyme
B (GrzB) expression was determined via flow cy-
tometry. A: Representative dot plots from one
mouse in each group are shown for CD8 T cells
gated by OVA-TET and positive for GrzB, and
demonstrate increased double-positive cells at
AAD as compared with LIT. B: The mean number
of GrzB postive OVA-TET CD8 T cells was
shown to be significantly elevated in the BAL and
lung tissue at AAD as compared with LIT. HLN
levels of GrzB were below detectable levels and
are not represented graphically. Data represent the
mean  SEM of four mice per group. *P  0.05.
o SIINFEKL peptide stimulation was increased in BAL and lung tissue at AAD.
CD8 T cells isolated from the BAL, lung tissue, and HLN. Intracellular IFN-
mouse in each group are shown for cells gated on CD8 T cells and IFN-
mpared with LIT. The percentage of IFN- CD8 T cells was shown to be




h LIT asitized and LIT animals were below detectable levels and are not represented
*P  0.01.
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also significantly increased in the lung compartments of
6-week discontinuously treated mice (BAL 13 103; lung
24  103; HLN 4  103) as compared with AAD rested
(no aerosol) mice (BAL 0.1 103, P 0.01; lung 3 103,
P  0.01; HLN 0.5  103, P  0.01; Figure 9B). Like the
6-week discontinuously treated mice, significant in-
creases were identified in the total number of eosinophils
and lymphocytes of 11-week discontinuously treated
mice compared with LIT rested animals (P  0.01, Figure
9C). These significant increases were also reflected in
the total number of OVA-TET CD8 T cells in the 11-
week discontinuously treated animals (BAL 1.8  103;
lung 11  103; HLN 3  103) compared with LIT rested
mice (no aerosol for 4 weeks) (BAL 0.1  103, P  0.01;
lung 2  103, P  0.01; HLN 1.5  103, P  0.05; Figure
9D). Similar increases were also seen in the percentage
of BAL eosinophils and lymphocytes between the discon-
tinuously treated and rested control groups (data not
shown).
Discussion
In a biphasic OVA-induced model of AAD, an endoge-
nous antigen-specific OVA-TET CD8 T cell response
developed in local lung compartments but not in sys-
temic tissues. The location and distribution of an endog-
enous antigen-specific CD8 T cell response has never
been examined at AAD or LIT (Figure 3 and 4).21,22 We
have demonstrated that systemic sensitization alone with
OVA and alum significantly increased the number of
OVA-TET CD8 T cells in lymphoid tissues as com-
pared with those found in naive mice by 10-fold. The
OVA-TET CD8 T cell response was further enhanced
in specific lung compartments post inhalation of OVA with
the development of AAD. Both the percentages and totalnumbers of OVA-TET CD8 T cells were higher in lung
tissue than in HLN at AAD and LIT, suggesting a local
lung tissue rather than lymphatic site of action. These
antigen-specific OVA-TET CD8 T cells associated with
B-cell aggregates in peribronchial and perivascular re-
gions of the lung. Formation and size of the aggregates
corresponded with the inflammatory stage of the disease,
with multiple high-density aggregates seen at AAD and
few low-density clusters observed at LIT. These transient
aggregates resemble tertiary ectopic lymphoid tissue
(TELT) or inducible bronchus associated lymph tissue
(iBALT), which have been reported to play an important
role in protective immunity against viral infections and to
support memory CD8 T cells in the absence of second-
ary lymph nodes.26,27 The aggregates appear more
TELT–like in that they lack the organization and vascula-
ture of a BALT structure, although no attempt at this time
has been made to further characterize the aggregates.
BALT–like structures are not uncommon in mice in re-
sponse to pathogens but, to our knowledge, have not
been implicated in asthma.
Changes in CD8 T cell densities and localizations
between AAD and LIT were accompanied by phenotypic
and functional differences in the cells. The OVA-TET
CD8 T cells in the local lung compartments at AAD and
LIT had an activated phenotype, with increased levels of
CD11a (LFA–1) and decreased levels of CD62L (L–Se-
lectin). The low expression of CD62L suggested that
most of the OVA-TET CD8 T cells were of an effector or
effector–memory phenotype.28 Unlike other tissues and
time points, CD11ahi and CD11alo OVA-TET CD8 T
cells were identified in the BAL at LIT. Previous studies
using viral infections have demonstrated that the two
populations represent either cells that have been in the
BAL for a prolonged period of time (CD11alo) or recent
Figure 9. Local lung OVA-TET CD8 T cells
were capable of re-expanding after re-exposure
to inhaled OVA in the 6-week and 11-week dis-
continuous animal models. Mice in the discon-
tinuous models with long periods of rest (no
inhaled OVA) were sacrificed, and OVA-TET
CD8 T cells were isolated from the BAL, lung
tissue, and HLN. In both the 6-week (A) and
11-week (C) discontinuous models, there was a
significant increase in the total number of BAL
eosinophils and lymphocytes as compared with
their respective rested controls. In a similar man-
ner, in both the 6-week (B) and 11-week (D)
discontinuous models, there was a significant
increase in the total number of OVA-TET CD8
T cells in the BAL and lung tissue compartments
as compared with their respective rested con-
trols. Data represent the mean  SEM of three to
eight mice per group. *P  0.05, **P  0.01.immigrants into the BAL (CD11ahi).29 Analogously, our
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T cells consisted almost entirely of recently recruited cells
(ie, 90% CD11ahi) whereas LIT BAL OVA-TET CD8
T cells were a combination of long-lived CD11alo (61%)
and recent immigrant CD11ahi (39%) cells maintained by
constant recruitment. These cells may be playing a role
in maintaining tolerance or participating in the inflam-
matory process but are not deleted by continued anti-
gen exposure.
In addition, we demonstrated that the regulatory NK
receptor, NKG2A, was minimally expressed on CD8 T
cells in sensitized animals but increased at AAD and
increased further at LIT in BAL and lung. The majority of
these NKG2A CD8 T cells were antigen specific OVA-
TET CD8 T cells. NKG2A affords preferential survival
to CD8 cells expressing it and has been demonstrated
to suppress CD8 T cell function.30–34 Furthermore, it
has been shown to be induced by transforming growth
factor–, which has been demonstrated to be an impor-
tant driver of tolerance in this biphasic OVA model.35,36
NKG2A has been associated with CD8 regulatory cells
and recently linked to suppressing B cell responses via T
follicular helper cells.37 The increased expression of
NKG2A may afford regulatory potential to the OVA-TET
CD8 T cells via interactions with its ligand Qa-1b, or it may
be inhibiting their pro-inflammatory effects and limiting lung
damage. Its presence suggests a possible inhibitory role for
OVA-TET CD8 T cells on potential Qa-1b B-cells and/or
Qa-1b CD4 effector T cells within the TELT-like aggre-
gates identified in the lung tissue.
Functionally, we demonstrated that expression of gran-
zyme B, an important molecule for cytotoxic killing, was
reserved to the antigen specific OVA-TET CD8 T cells in
the BAL and lung at AAD but not found in these cells at
LIT or in the HLN. These observations correlate with clin-
ical findings, which have identified increased levels of
granzyme B in the BAL of asthma patients while being
decreased in the serum.38,39 Similarly, we demonstrated
that CD8 T cells in the BAL and lung at AAD produced
increased IFN-, a Tc1 cytokine. The presence of gran-
zyme B positive CD8 T cells and IFN- CD8 T cells at
AAD and their absence at LIT suggest a functional plas-
ticity in the lung microenvironment. The increased ex-
pression of granzyme B and NKG2A by OVA-TET CD8
T cells suggests that these cells are capable of direct
killing, potentially of antigen-activated Qa-1b CD4 ef-
fector T cells.25
Collectively, changes in phenotypic (CD11ahi, CD62L,
and NKG2A) and functional (granzyme B and IFN-)
markers illustrate plasticity in the OVA-TET CD8 T cell
response, which may contribute to the development of
AAD and/or LIT. Conceivably, TELT-like structures seen
at AAD may be needed to establish a local environment
conducive for intercellular communication. This environ-
ment may contribute to optimal signaling exchange for
switchover to a regulatory phenotype and may promote
the establishment of LIT.
Uniquely, our discontinuous models (Figure 1B) al-
lowed us to examine the ability of antigen-specific CD8
T cells generated at AAD or LIT to respond to re-expo-
sure of aerosolized antigen (Figure 9). As we have pre-viously described,19 resting (ie, no aerosol exposure to
OVA) either AAD or LIT animals and re-exposing them to
OVA aerosol (6-week or 11-week discontinuous model),
resulted in the return of AAD with increased BAL eosin-
ophils. In both cases, the expansion of eosinophils in the
BAL was accompanied by significant increases in the
percentages and numbers of OVA-TET CD8 T cells in
the BAL and lung tissue, demonstrating that the OVA-
TET CD8 T cells generated at AAD or LIT were respon-
sive to antigen re-challenge and were not permanently
exhausted. Such a CD8 memory response has been
suggested as an ideal target for a vaccination strategy for
asthma.40,41 Several vaccination studies have demon-
strated the increased production of IFN- from CD8 T
cells and have suggested it as a mechanism of limiting
asthma. Our data demonstrate that antigen-specific
IFN- CD8 T cells developed at AAD and may con-
tribute to the development of LIT.
In summary, in our biphasic OVA murine asthma
model, antigen-specific CD8 T cells in the local lung
compartments at AAD appeared as typical activated ef-
fector cells (CD11ahi,CD62L, expressing granzyme B,
and IFN-) whereas at LIT these CD8 T cells appeared
to be regulatory, with increased expression of NKG2A
and no ability to express granzyme B or IFN-. The pos-
sible plasticity of these CD8 T cells exists in a somewhat
analogous manner as has been seen to occur in murine
asthma models with a shift from CD4Foxp3 T effector
cells to CD4Foxp3 regulatory cells. An alternative to a
plasticity paradigm is the recruitment of new subpopula-
tions of suppressive/regulatory CD8 T cells phenotypi-
cally expressing NKG2A. It is intriguing to consider that
the formation of the TELT-like structures provides the
appropriate local environment for either of these para-
digms while preserving homeostatic systemic respon-
siveness. Structures such as iBALT have been shown to
be present in the lungs of asthmatic individuals.42 What
roles CD8 T cells and these TELT-like aggregates may
play in AAD and in the induction of tolerance at LIT
remain unresolved; nonetheless, these results could pro-
vide important insight into this biphasic model and aller-
gic reactions in general, calling for further examination in
future studies.
References
1. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of
lymphokine secretion lead to different functional properties. Annu Rev
Immunol 1989, 7:145–173
2. Ricci M, Rossi O, Bertoni M, Matucci A: The importance of Th2-like
cells in the pathogenesis of airway allergic inflammation. Clin Exp
Allergy 1993, 23:360–369
3. Larche M, Robinson DS, Kay AB: The role of T lymphocytes in the
pathogenesis of asthma. J Allergy Clin Immunol 2003, 111:450–463
4. Carson WF 4th, Guernsey LA, Singh A, Vella AT, Schramm CM, Thrall
RS: Accumulation of regulatory T cells in local draining lymph nodes
of the lung correlates with spontaneous resolution of chronic asthma
in a murine model. Int Arch Allergy Immunol 2008, 145:231–243
5. Venuprasad K, Kong YC, Farrar MA: Control of Th2-mediated inflam-
mation by regulatory T cells. Am J Pathol 2010, 177:525–5316. Woodland DL, Dutton RW: Heterogeneity of CD4() and CD8() T
cells. Curr Opin Immunol 2003, 15:336–342
2000 McNamara et al
AJP May 2012, Vol. 180, No. 57. Lefrançois L, Obar JJ: Once a killer, always a killer: from cytotoxic T
cell to memory cell. Immunol Rev 2010, 235:206–218
8. Betts RJ, Kemeny DM: CD8 T cells in asthma: friend or foe? Phar-
macol Ther 2009, 121:123–131
9. Hamelmann E, Oshiba A, Paluh J, Bradley K, Loader J, Potter TA,
Larsen GL, Gelfand EW: Requirement for CD8 T cells in the devel-
opment of airway hyperresponsiveness in a murine model of airway
sensitization. J Exp Med 1996, 183:1719–1729
10. Leggat JA, Gibbons DL, Haque SF, Smith AL, Wells JW, Choy K,
Lloyd CM, Hayday AC, Noble A: Innate responsiveness of CD8
memory T-cell populations nonspecifically inhibits allergic sensitiza-
tion. J Allergy Clin Immunol 2008, 122:1014–1021
11. Miyahara N, Swanson BJ, Takeda K, Taube C, Miyahara S, Kodama
T, Dakhama A, Ott VL, Gelfand EW: Effector CD8 T cells mediate
inflammation and airway hyper-responsiveness. Nat Med 2004, 10:
865–869
12. Stock P, Kallinich T, Akbari O, Quarcoo D, Gerhold K, Wahn U,
Umetsu DT, Hamelmann E: CD8() T cells regulate immune re-
sponses in a murine model of allergen-induced sensitization and
airway inflammation. Eur J Immunol 2004, 34:1817–1827
13. Koya T, Miyahara N, Takeda K, Matsubara S, Matsuda H, Swasey C,
Balhorn A, Dakhama A, Gelfand EW: CD8 T cell-mediated airway
hyperresponsiveness and inflammation is dependent on CD4IL-4
T cells. J Immunol 2007, 179:2728–2796
14. Sawicka E, Noble A, Walker C, Kemeny DM: Tc2 cells respond to
soluble antigen in the respiratory tract and induce lung eosinophilia
and bronchial hyperresponsiveness. Eur J Immunol 2004, 34:2599–
2608
15. Sedgwick JD, Holt PG: Suppression of IgE responses in inbred rats
by repeated respiratory tract exposure to antigen: responder pheno-
type influences isotype specificity of induced tolerance. Eur J Immu-
nol 1984, 14:893–897
16. Suzuki M, Taha R, Ihaku D, Hamid Q, Martin JG: CD8 T cells
modulate late allergic airway responses in Brown Norway rats. J Im-
munol 1999, 163:5574–5581
17. Aguilar-Pimentel JA, Alessandrini F, Huster KM, Jakob T, Schulz H,
Behrendt H, Ring J, de Angelis MH, Busch DH, Mempel M, Ollert M:
Specific CD8 T cells in IgE-mediated allergy correlate with allergen
dose and allergic phenotype. Am J Respir Crit Care Med 2010,
181:7–16
18. Yiamouyiannis CA, Schramm CM, Puddington L, Stengel P, Bara-
daran-Hosseini E, Wolyniec WW, Whitley HE, Thrall RS: Shifts in lung
lymphocyte profiles correlate with the sequential development of
acute allergic and chronic tolerant stages in a murine asthma model.
Am J Pathol 1999, 154:1911–1921
19. Schramm CM, Puddington L, Wu C, Guernsey L, Gharaee-Kermani
M, Phan SH, Thrall RS: Chronic inhaled ovalbumin exposure induces
antigen-dependent but not antigen-specific inhalational tolerance in a
murine model of allergic airway disease. Am J Pathol 2004, 164:295–
304
20. Van den Broeck W, Derore A, Simoens P: Anatomy and nomenclature
of murine lymph nodes: descriptive study and nomenclatory stan-
dardization in BALB/cAnNCrl mice. J Immunol Methods 2006, 312:
12–19
21. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams
MG, Bell JI, McMichael AJ, Davis MM: Phenotypic analysis of anti-
gen-specific T lymphocytes. Science 1996, 274:94–96
22. Obar JJ, Khanna KM, Lefrancois L: Endogenous naive CD8 T cell
precursor frequency regulates primary and memory responses to
infection. Immunity 2008, 28:859–869
23. Khanna KM, Bonneau RH, Kinchington PR, Hendricks RL: Herpes
simplex virus-specific memory CD8 T cells are selectively activated
and retained in latently infected sensory ganglia. Immunity 2003,
18:593–60324. Khanna KM, McNamara JT, Lefrancois L: In situ imaging of the
endogenous CD8 T cell response to infection. Science 2007, 318:
116–120
25. Lu L, Werneck MB, Cantor H: The immunoregulatory effects of Qa-1.
Immunol Rev 2006, 212:51–59
26. Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, Kusser K, Randall
TD: Pulmonary expression of CXC chemokine ligand 13, CC chemo-
kine ligand 19, and CC chemokine ligand 21 is essential for local
immunity to influenza. Proc Natl Acad Sci USA 2007, 104:10577–
10582
27. Moyron-Quiroz JE, Rangel-Moreno J, Hartson L, Kusser K, Tighe MP,
Klonowski KD, Lefrancois L, Cauley LS, Harmsen AG, Lund FE,
Randall TD: Persistence and responsiveness of immunologic memory
in the absence of secondary lymphoid organs. Immunity 2006, 25:
643–654
28. Obar JJ, Lefrancois L: Memory CD8 T cell differentiation. Ann NY
Acad Sci 2010, 1183:251–266
29. Ely KH, Cookenham T, Roberts AD, Woodland DL: Memory T cell
populations in the lung airways are maintained by continual recruit-
ment. J Immunol 2006, 176:537–543
30. McMahon CW, Zajac AJ, Jamieson AM, Corral L, Hammer GE,
Ahmed R, Raulet DH: Viral and bacterial infections induce expression
of multiple NK cell receptors in responding CD8() T cells. J Immunol
2002, 169:1444–1452
31. Gunturi A, Berg RE, Forman J: The role of CD94/NKG2 in innate and
adaptive immunity. Immunol Res 2004, 30:3429–3432
32. Gunturi A, Berg RE, Forman J: Preferential survival of CD8 T and NK
cells expressing high levels of CD94. J Immunol 2003, 170:1737–
1745
33. Zhou J, Matsuoka M, Cantor H, Homer R, Enelow RI: Cutting edge:
engagement of NKG2A on CD8 effector T cells limits immunopa-
thology in influenza pneumonia. J Immunol 2008, 180:25–29
34. Gunturi A, Berg RE, Crossley E, Murray S, Forman J: The role of TCR
stimulation and TGF-beta in controlling the expression of CD94/
NKG2A receptors on CD8 T cells. Eur J Immunol 2005, 35:766–775
35. Ostroukhova M, Seguin-Devaux C, Oriss TB, Dixon-McCarthy B,
Yang L, Ameredes BT, Corcoran TE, Ray A: Tolerance induced by
inhaled antigen involves CD4() T cells expressing membrane-
bound TGF-beta and FOXP3. J Clin Invest 2004, 114:28–38
36. Singh A, Carson WF, 4th, Secor ER Jr., Guernsey LA, Flavell RA, Clark
RB, Thrall RS, Schramm CM: Regulatory role of B cells in a murine
model of allergic airway disease. J Immunol 2008, 180:7318–7326
37. Kim HJ, Verbinnen B, Tang X, Lu L, Cantor H: Inhibition of follicular
T-helper cells by CD8() regulatory T cells is essential for self toler-
ance. Nature 2010, 467:328–332
38. Bratke K, Bottcher B, Leeder K, Schmidt S, Kupper M, Virchow JC Jr.,
Luttmann W: Increase in granzyme B lymphocytes and soluble
granzyme B in bronchoalveolar lavage of allergen challenged pa-
tients with atopic asthma. Clin Exp Immunol 2004, 136:542–548
39. Bratke K, Haupt F, Kuepper M, Bade B, Faehndrich S, Luttmann W,
Virchow JC, Jr: Decrease of cytotoxic T cells in allergic asthma
correlates with total serum immunglobulin E. Allergy 2006, 61:1351–
1357
40. Takeda K, Dow SW, Miyahara N, Kodama T, Koya T, Taube C,
Joetham A, Park JW, Dakhama A, Kedl RM, Gelfand EW: Vaccine-
induced CD8 T cell-dependent suppression of airway hyperrespon-
siveness and inflammation. J Immunol 2009, 183:181–190
41. Wells JW, Choy K, Lloyd CM, Noble A: Suppression of allergic airway
inflammation and IgE responses by a class I restricted allergen
peptide vaccine. Mucosal Immunol 2009, 2:54–62
42. Elliot JG, Jensen CM, Mutavdzic S, Lamb JP, Carroll NG, James AL:
Aggregations of lymphoid cells in the airways of nonsmokers, smok-
ers, and subjects with asthma. Am J Respir Crit Care Med 2004,
69:712–718
